Dupont Capital Management Corp Eiger Bio Pharmaceuticals, Inc. Transaction History

Dupont Capital Management Corp

  • $1.14 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022
SELL
$4.99 - $8.96 $186,591 - $335,041
-37,393 Closed
0 $0
Q1 2022

Apr 27, 2022
BUY
$3.84 - $9.74 $55,676 - $141,220
14,499 Added 63.33%
37,393 $310,000
Q4 2021

Jan 31, 2022
SELL
$5.12 - $8.19 $46,735 - $74,758
-9,128 Reduced 28.51%
22,894 $119,000
Q3 2021

Nov 03, 2021
BUY
$6.68 - $9.1 $213,906 - $291,400
32,022 New
32,022 $214,000

Others Institutions Holding EIGR

# of Institutions
6
Shares Held
748K
Call Options Held
0
Put Options Held
0
View Full List

About Eiger BioPharmaceuticals, Inc.

EIGR Quotes by TradingView
  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $418M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email